9-136503276-C-T

Variant summary

Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2

The NM_017617.5(NOTCH1):​c.5073G>A​(p.Gln1691Gln) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0045 in 1,613,022 control chromosomes in the GnomAD database, including 25 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0033 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0046 ( 25 hom. )

Consequence

NOTCH1
NM_017617.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:14

Conservation

PhyloP100: 0.270
Variant links:
Genes affected
NOTCH1 (HGNC:7881): (notch receptor 1) This gene encodes a member of the NOTCH family of proteins. Members of this Type I transmembrane protein family share structural characteristics including an extracellular domain consisting of multiple epidermal growth factor-like (EGF) repeats, and an intracellular domain consisting of multiple different domain types. Notch signaling is an evolutionarily conserved intercellular signaling pathway that regulates interactions between physically adjacent cells through binding of Notch family receptors to their cognate ligands. The encoded preproprotein is proteolytically processed in the trans-Golgi network to generate two polypeptide chains that heterodimerize to form the mature cell-surface receptor. This receptor plays a role in the development of numerous cell and tissue types. Mutations in this gene are associated with aortic valve disease, Adams-Oliver syndrome, T-cell acute lymphoblastic leukemia, chronic lymphocytic leukemia, and head and neck squamous cell carcinoma. [provided by RefSeq, Jan 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -15 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.46).
BP6
Variant 9-136503276-C-T is Benign according to our data. Variant chr9-136503276-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 241146.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-136503276-C-T is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=0.27 with no splicing effect.
BS2
High AC in GnomAd4 at 505 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
NOTCH1NM_017617.5 linkuse as main transcriptc.5073G>A p.Gln1691Gln synonymous_variant 27/34 ENST00000651671.1 NP_060087.3 P46531
NOTCH1XM_011518717.3 linkuse as main transcriptc.4350G>A p.Gln1450Gln synonymous_variant 24/31 XP_011517019.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
NOTCH1ENST00000651671.1 linkuse as main transcriptc.5073G>A p.Gln1691Gln synonymous_variant 27/34 NM_017617.5 ENSP00000498587.1 P46531

Frequencies

GnomAD3 genomes
AF:
0.00332
AC:
505
AN:
152214
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000941
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00438
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00248
Gnomad FIN
AF:
0.000941
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00547
Gnomad OTH
AF:
0.00192
GnomAD3 exomes
AF:
0.00326
AC:
809
AN:
248234
Hom.:
5
AF XY:
0.00335
AC XY:
453
AN XY:
135150
show subpopulations
Gnomad AFR exome
AF:
0.000715
Gnomad AMR exome
AF:
0.00240
Gnomad ASJ exome
AF:
0.0000999
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00284
Gnomad FIN exome
AF:
0.000933
Gnomad NFE exome
AF:
0.00514
Gnomad OTH exome
AF:
0.00498
GnomAD4 exome
AF:
0.00463
AC:
6758
AN:
1460690
Hom.:
25
Cov.:
34
AF XY:
0.00458
AC XY:
3329
AN XY:
726636
show subpopulations
Gnomad4 AFR exome
AF:
0.000388
Gnomad4 AMR exome
AF:
0.00244
Gnomad4 ASJ exome
AF:
0.0000765
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00237
Gnomad4 FIN exome
AF:
0.00147
Gnomad4 NFE exome
AF:
0.00551
Gnomad4 OTH exome
AF:
0.00373
GnomAD4 genome
AF:
0.00332
AC:
505
AN:
152332
Hom.:
0
Cov.:
33
AF XY:
0.00326
AC XY:
243
AN XY:
74490
show subpopulations
Gnomad4 AFR
AF:
0.000938
Gnomad4 AMR
AF:
0.00438
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00249
Gnomad4 FIN
AF:
0.000941
Gnomad4 NFE
AF:
0.00547
Gnomad4 OTH
AF:
0.00190
Alfa
AF:
0.00404
Hom.:
0
Bravo
AF:
0.00290
Asia WGS
AF:
0.00202
AC:
7
AN:
3478
EpiCase
AF:
0.00442
EpiControl
AF:
0.00421

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:14
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJan 01, 2024NOTCH1: BP4, BP7, BS1, BS2 -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Likely benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, Amsterdam University Medical Center-- -
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 05, 2023- -
not specified Benign:3
Benign, criteria provided, single submitterclinical testingGeneDxJan 24, 2018This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpJul 21, 2023- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Apr 06, 2017- -
Familial thoracic aortic aneurysm and aortic dissection Benign:2
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsFeb 20, 2015This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Benign, criteria provided, single submitterclinical testingCHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern OntarioNov 29, 2017- -
Adams-Oliver syndrome 5 Benign:2
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabMar 15, 2022- -
Aortic valve disease 1 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabMar 15, 2022- -
Connective tissue disorder Benign:1
Likely benign, criteria provided, single submitterclinical testingCenter for Human Genetics, Inc, Center for Human Genetics, IncNov 01, 2016- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.46
CADD
Benign
5.9
DANN
Benign
0.91

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs61751538; hg19: chr9-139397728; COSMIC: COSV104541427; API